Potential Therapeutic Agents against Paclitaxel—And Sorafenib-Resistant Papillary Thyroid CarcinomaSeok‐Mo Kim, Ki Cheong Park|International Journal of Molecular Sciences|2022Cited by 11
Identification of new small molecules for selective inhibition of SERCA 1 in patient‐derived metastatic papillary thyroid cancerSeok‐Mo Kim, Ki Cheong Park|British Journal of Pharmacology|2025Cited by 3
Co-inhibition of glutaminolysis and one carbon metabolism promotes ROS accumulation leading to enhancement of chemotherapeutic efficacy in anaplastic thyroid cancerSungsoon Fang, Seok‐Mo Kim|Research Square|2023Cited by 0